Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that it has priced a registered direct offering of its common stock for approximately $31.9 million in gross proceeds. Under the terms of the financing, Barrier will sell approximately 5.5 million shares of its common stock at $5.75 per share to a select ...
From: biz.yahoo.com
Barrier Therapeutics to Raise $31.9 Million in Registered Direct Offering of Common Stock
Posted by Ruslan Abuzant at 8:57 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment